​​​​​​Teen Vaping Study

Michael Berry
UC Berkeley/UCSF
Graduate Student
Contact: mikehberry@berkeley.edu

Karma received her PhD in public health in 2014. Her dissertation work focused on time trends and determinants of initiation for waterpipe and cigarette smoking among a cohort of Jordanian school children. Understanding smoking trends and risk factors associated with initiation among youth anywhere in the world is important for prevention intervention programming and public policy planning. Karma’s specialization in public health is epidemiology. As a public health epidemiologist she is dedicated to creating valid and reliable measurement tools (or validating those that are already in use) and to designing effective interventions that can be deployed, replicated, and the results interpreted with ease.

Dr. Ramois an Assistant Professor and licensed psychologist in the Department of Psychiatry at the University of California, San Francisco (UCSF). Her research focuses on adolescent and young adult substance abuse, with an emphasis on using social media to help young people change health risk behaviors.

Currently, Dr. Ramo is funded through a grant from the National Institute on Drug Abuse to design and evaluate the efficacy of a smoking cessation intervention for young adults delivered on Facebook. To inform this project, she recently conducted a mixed-methods study to evaluate young adults’ receptivity to a Facebook-based intervention to reduce tobacco use, demonstrating interest and importance of tailoring intervention to readiness to quit smoking.

Dr. Ramo serves as program faculty and advises fellows and trainees in the NIDA-funded P50 San Francisco Treatment Research Center, the Postdoctoral Traineeship in Substance Abuse Treatment and Services Research, the UCSF Helen Diller Comprehensive Cancer Center, and the Center for Tobacco Control Research and Education in the UCSF School of Medicine.

Before joining the faculty at UCSF, Dr. Ramo was a fellow in the NIDA T32-funded Substance Abuse Treatment and Services Research Training Program at UCSF, and had an individual postdoctoral fellowship from the California Tobacco-Related Diseases Research Training Program to conduct online survey studies with young adult smokers. Her research has demonstrated the high level of co-use of tobacco and marijuana, yet marked differences in motivation and thoughts about abstinence among those who use both substances. Additional publications during her postgraduate work have focused on longitudinal patterns of polysubstance use and recruitment and validation of substance abuse reports online.

Dr. Ramo co-leads a Leadership Seminar for senior trainees in the UCSF Department of Psychiatry and regularly teaches smoking cessation to medical students at UCSF. She also serves on the Scientific Advisory Board of the Being Adept prevention intervention program (Beingadept.org), helping to design curriculum and speaking to parents and school administrators about prevention of substance abuse throughout Marin, Sonoma, and San Francisco counties.

Dr. Ramo obtained her B.A. from Columbia University and her Ph.D. from the San Diego State University/University of California, San Diego Joint Doctoral Program in Clinical Psychology.

Dr. Rubinstein has devoted his career to the care and research of adolescents. Dr. Rubinstein completed his medical education and internal medicine residency at the Yale School of Medicine. He then went on to complete a fellowship in adolescent medicine at the University of California San Francisco. He is board-certified in internal medicine and adolescent medicine.

Dr. Rubinstein joined the faculty of the Department of Pediatrics in the Division of Adolescent Medicine at the University of California, San Francisco in 2003.  He has been the director of the Adolescent Medicine Fellowship since 2011. As part of his commitment to academic excellence within the university, Dr. Rubinstein serves as co-director of the adolescent medicine block of the Life Cycle course, and is a member of the UCSF Scholarship Oversight Committee.

Dr. Rubinstein is a member of the Society of Adolescent Health and Medicine, the Society for Research on Nicotine and Tobacco, and the Society for Pediatric Research.

He has taken active leadership roles in both the Society of Adolescent Health and Medicine and has served as the director of programs. Dr. Rubinstein’s research interests are in the development of addiction during adolescence. 

Richard Daniel Ceballos III
Clinical Research Coordinator for e-Cigarette/Vape Study 
University of California, San Francisco 
Mobile: (909) 244-8592

Mark L. Rubinstein, MD
Associate Professor of Pediatrics
Principal Investigator
University of California, San Francisco
Contact: Mark.Rubinstein@ucsf.edu


Danielle Ramo, Ph.D.
Assistant Professor of Psychiatry
Principal Investigator
University of California, San Francisco
Contact: Danielle.Ramo@ucsf.edu

Karma McKelvey
University of California, San Francisco
Contact: Karma.McKelvey

Richard graduated from UC Berkeley in Fall 2013 with a B.A. in Integrative Biology and is interested in pursuing a career in medicine. While attending UC Berkeley, he was deeply involved in serving underrepresented communities in the fields of education and health care. Intensive hours spent at Alta Bates Medical Center in Oakland and his tutoring/mentoring at Berkeley High School and UC Berkeley revealed his will to connect and empower lives through science. After graduating from UC Berkeley, he was able to strengthen his ability to provide quality patient care by working at a fertility clinic in San Francisco and serving as a HIV counselor. As the Clinical Research Coordinator of this study, he hopes to combine his experiences to manage the overall day-to-day flow of recruiting and overseeing the participants in a compassionate and consistent manner.Type your paragraph here.

Michael completed his undergraduate studies at UC Berkeley in Molecular Biology and is currently pursuing a masters in Translational Medicine at UCSF. His research background is in therapeutics and his interest resides in preventative approaches to disease treatment. Michael was born in South Africa, strongly influencing his interest in community-support. Exposure to first world medicine in the United States and international outreach in Kenya has drawn him to the rewards and challenges of healthcare within diverse populations. He hopes to pursue a career in medicine, improving and conducting culturally and environmentally specific patient treatments by combining research and care.